Actimed Therapeutics announced £5M series A round
27 June 2023
27 June 2023
Total investments received (USD): 12.43m
Round value (USD): 6.32m
Round investors:
Mankind Pharma
Company: Actimed Therapeutics
Related deals
Glox Therapeutics in a £4.3M seed round of funding led by Boehringer Ingelheim Venture Fund (BIVF) and Scottish Enterprise.
Investments
04 November 2023
Valink Therapeutics raised $7.8M seed led by RV Invest, joined by Hoxton, SynBioVen, Metaplanet, Acequia Capital, Magnet Venture, Oxford Angel Fund.
Investments
14 October 2023
Actimed Therapeutics in a £4.75m series A extension
Investments
18 August 2023
Camena Bioscience closed a £7.8M Series A financing round, led by Mercia.
Investments
30 June 2023
PharmEnable to raise £6M in a round backed by Cambridge Enterprise et al
Investments
01 May 2023
Belgium
Netherlands
Austria
Switzerland
Denmark
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain